or Try an Advanced Search...

    Technical Analysis for SRRK - Scholar Rock Holding Corporation

    Grade Last Price % Change Price Change
    F 9.28 -1.80% -0.17
    SRRK closed down 1.8 percent on Friday, July 26, 2024, on 64 percent of normal volume. It ran into resistance at its 50 day moving average.
    Earnings due: Aug 7
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Up
    Historical SRRK trend table...
    Date Alert Name Type % Chg
    50 DMA Resistance Bearish 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    50 DMA Resistance Bearish -1.80%
    20 DMA Support Bullish -1.80%
    Pocket Pivot Bullish Swing Setup -1.80%
    Outside Day Range Expansion -1.80%
    Shooting Star Candlestick Bearish 0.87%
    Lizard Bearish Bearish Day Trade Setup 0.87%
    Doji - Bearish? Reversal 0.87%
    Pocket Pivot Bullish Swing Setup 0.65%
    Older End-of-Day Signals for SRRK ...

       Recent Intraday Alerts

    Alert Time
    Down 2 % about 16 hours ago
    Down 1% about 17 hours ago
    60 Minute Opening Range Breakdown about 17 hours ago
    Rose Above Upper Bollinger Band about 17 hours ago
    Upper Bollinger Band Resistance about 17 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    SRRK Chart by TradingView
    Basic chart:

    Profile

    Scholar Rock Holding Corp is a biopharmaceutical company. It is engaged in the discovery and development of innovative medicines for the treatment of serious diseases including neuromuscular disorders, cancer, fibrosis, and anemia.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Natural Sciences Medication Anemia Fibrosis Neuromuscular Disorders

    Is SRRK a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jul 23 Scholar Rock to Host Conference Call to Discuss Second Quarter 2024 Financial Results and Provide Business Update on August 8, 2024
    Jul 8 Scholar Rock Holding Corporation (SRRK): The Most Shorted Stock Loved by Analysts?
    Jun 24 Scholar Rock provides preclinical data for its investigational obesity candidate
    Jun 24 Scholar Rock Announces New SRK-439 Preclinical Data Showing Significant Lean Mass Preservation and Attenuation of Fat Mass Rebound Following GLP-1 Receptor Agonist Withdrawal
    Jun 3 Scholar Rock Presents New Data from SRK-181 Phase 1 DRAGON Trial at ASCO 2024 Annual Meeting
    May 28 Scholar Rock to Present New Data from SRK-181 Phase 1 DRAGON Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting
    May 22 Scholar Rock Announces Initiation of Phase 2 EMBRAZE Trial of Apitegromab in Obesity and New Preclinical Data Supporting SRK-439 in Obesity
    May 20 Scholar Rock to Participate in Upcoming Investor Conferences
    May 14 Scholar Rock to Host Investor Day on May 22, 2024
    May 7 Scholar Rock Holding Corp (SRRK) Reports Q1 2024 Financial Results: A Detailed Analysis
    See more SRRK news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 21.17
    52 Week Low 5.93
    Average Volume 1,003,146
    200-Day Moving Average 13.18
    50-Day Moving Average 9.44
    20-Day Moving Average 8.63
    10-Day Moving Average 9.09
    Average True Range 0.61
    RSI (14) 53.49
    ADX 18.88
    +DI 25.38
    -DI 18.31
    Chandelier Exit (Long, 3 ATRs) 8.02
    Chandelier Exit (Short, 3 ATRs) 9.37
    Upper Bollinger Bands 9.83
    Lower Bollinger Band 7.43
    Percent B (%b) 0.77
    BandWidth 27.79
    MACD Line -0.02
    MACD Signal Line -0.20
    MACD Histogram 0.1729
    Fundamentals Value
    Market Cap 669.49 Million
    Num Shares 72.1 Million
    EPS -1.95
    Price-to-Earnings (P/E) Ratio -4.76
    Price-to-Sales 11.33
    Price-to-Book 6.63
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 10.24
    Resistance 3 (R3) 10.33 10.09 10.08
    Resistance 2 (R2) 10.09 9.85 10.05 10.03
    Resistance 1 (R1) 9.69 9.70 9.57 9.60 9.97
    Pivot Point 9.45 9.45 9.40 9.41 9.45
    Support 1 (S1) 9.05 9.21 8.93 8.96 8.59
    Support 2 (S2) 8.81 9.06 8.77 8.53
    Support 3 (S3) 8.41 8.81 8.48
    Support 4 (S4) 8.32